-
2
-
-
42349087252
-
Microvascular and macrovascular complications of diabetes
-
Fowler M.J. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008, 26:77-82.
-
(2008)
Clin Diabetes
, vol.26
, pp. 77-82
-
-
Fowler, M.J.1
-
3
-
-
84927175978
-
-
US Department of Veterans Affairs, Washington D.C., USA, Available from [cited 2013 Apr 24]
-
Quality Enhancement Research Initiative Diabetes Quality Enhancement Research Initiative [Internet] 2013, US Department of Veterans Affairs, Washington D.C., USA, Available from: http://www.queri.research.va.gov/dm/ [cited 2013 Apr 24].
-
(2013)
Diabetes Quality Enhancement Research Initiative [Internet]
-
-
-
4
-
-
2342479925
-
Who has diabetes? Best estimates of diabetes prevalence in the department of veterans affairs based on computerized patient data
-
Miller D.R., Safford M.M., Pogach L.M. Who has diabetes? Best estimates of diabetes prevalence in the department of veterans affairs based on computerized patient data. Diabetes Care 2004, 27(SUPPL. 2):b10-b21.
-
(2004)
Diabetes Care
, vol.27
, pp. b10-b21
-
-
Miller, D.R.1
Safford, M.M.2
Pogach, L.M.3
-
5
-
-
2342475891
-
Diabetes in nonveterans, veterans, and veterans receiving department of veterans affairs health care
-
Reiber G.E., Koepsell T.D., Maynard C., Haas L.B., Boyko E.J. Diabetes in nonveterans, veterans, and veterans receiving department of veterans affairs health care. Diabetes Care 2004, 27(SUPPL. 2):b3-b9.
-
(2004)
Diabetes Care
, vol.27
, pp. b3-b9
-
-
Reiber, G.E.1
Koepsell, T.D.2
Maynard, C.3
Haas, L.B.4
Boyko, E.J.5
-
6
-
-
2342624692
-
Diabetes-related utilization and costs for inpatient and outpatient services in the veterans administration
-
Maciejewski M.L., Maynard C. Diabetes-related utilization and costs for inpatient and outpatient services in the veterans administration. Diabetes Care 2004, 27(SUPPL. 2):b69-b73.
-
(2004)
Diabetes Care
, vol.27
, pp. b69-b73
-
-
Maciejewski, M.L.1
Maynard, C.2
-
7
-
-
80054068448
-
Insulin preparations with prolonged effect
-
Owens D.R. Insulin preparations with prolonged effect. Diabetes Technol Ther 2011, 13(SUPPL. 1):S5-S14.
-
(2011)
Diabetes Technol Ther
, vol.13
, pp. S5-S14
-
-
Owens, D.R.1
-
8
-
-
61449244692
-
Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis
-
Singh S.R., Ahmad F., Lal A., Yu C., Bai Z., Bennett H. Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis. CMAJ 2009, 180:385-397.
-
(2009)
CMAJ
, vol.180
, pp. 385-397
-
-
Singh, S.R.1
Ahmad, F.2
Lal, A.3
Yu, C.4
Bai, Z.5
Bennett, H.6
-
9
-
-
26944477362
-
Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial
-
Heine R.J., Van Gaal L.F., Johns D., Mihm M.J., Widel M.H., Brodows R.G. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med 2005, 143:559-569.
-
(2005)
Ann Intern Med
, vol.143
, pp. 559-569
-
-
Heine, R.J.1
Van Gaal, L.F.2
Johns, D.3
Mihm, M.J.4
Widel, M.H.5
Brodows, R.G.6
-
10
-
-
84864360856
-
1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide
-
1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide. Diabetes Obes Metab 2012, 14:826-834.
-
(2012)
Diabetes Obes Metab
, vol.14
, pp. 826-834
-
-
Paul, S.1
Best, J.2
Klein, K.3
Han, J.4
Maggs, D.5
-
11
-
-
51549095571
-
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study
-
Moretto T.J., Milton D.R., Ridge T.D., Maconnell L.A., Okerton T., Wolka A.M., et al. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 2008, 30:1448-1460.
-
(2008)
Clin Ther
, vol.30
, pp. 1448-1460
-
-
Moretto, T.J.1
Milton, D.R.2
Ridge, T.D.3
Maconnell, L.A.4
Okerton, T.5
Wolka, A.M.6
-
12
-
-
37349008890
-
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial
-
Barnett A.H., Burger J., Johns D., Brodows R., Kendall D.M., Roberts A., et al. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial. Clin Ther 2007, 29:2333-2348.
-
(2007)
Clin Ther
, vol.29
, pp. 2333-2348
-
-
Barnett, A.H.1
Burger, J.2
Johns, D.3
Brodows, R.4
Kendall, D.M.5
Roberts, A.6
-
13
-
-
79551615182
-
Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial
-
Buse J.B., Bergenstal R.M., Glass L.C., Heilmann C.R., Lewis M.S., Kwan A.Y., et al. Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial. Ann Intern Med 2011, 154:103-112.
-
(2011)
Ann Intern Med
, vol.154
, pp. 103-112
-
-
Buse, J.B.1
Bergenstal, R.M.2
Glass, L.C.3
Heilmann, C.R.4
Lewis, M.S.5
Kwan, A.Y.6
-
14
-
-
79951870602
-
Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes
-
Bunck M.C., Eliasson B., Cornér A., Heine R.J., Shaginian R.M., Taskinen M.R., et al. Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes. Diabetes Obes Metab 2011, 13:374-377.
-
(2011)
Diabetes Obes Metab
, vol.13
, pp. 374-377
-
-
Bunck, M.C.1
Eliasson, B.2
Cornér, A.3
Heine, R.J.4
Shaginian, R.M.5
Taskinen, M.R.6
-
15
-
-
84927176110
-
-
U.S. Dept. of Veterans Affairs, Health Services Research and Development Service, VA Information Resource Center, Hines, IL
-
VA Information Resource Center VIReC resource guide: VA corporate data warehouse 2012, U.S. Dept. of Veterans Affairs, Health Services Research and Development Service, VA Information Resource Center, Hines, IL.
-
(2012)
VIReC resource guide: VA corporate data warehouse
-
-
-
16
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
-
Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
-
(1987)
J Chronic Dis
, vol.40
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
MacKenzie, C.R.4
-
17
-
-
84858019933
-
Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes
-
Farmer A.J., Perera R., Ward A., Heneghan C., Oke J., Barnett A.H., et al. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ 2012, 344:e486.
-
(2012)
BMJ
, vol.344
, pp. e486
-
-
Farmer, A.J.1
Perera, R.2
Ward, A.3
Heneghan, C.4
Oke, J.5
Barnett, A.H.6
-
18
-
-
77950651886
-
Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type 2 diabetes: systematic review
-
Clar C., Barnard K., Cummins E., Royle P., Waugh N. Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010, 14:1-140.
-
(2010)
Health Technol Assess
, vol.14
, pp. 1-140
-
-
Clar, C.1
Barnard, K.2
Cummins, E.3
Royle, P.4
Waugh, N.5
-
19
-
-
0035488933
-
Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection
-
Tsui E., Barnie A., Ross S., Parkes R., Zinman B. Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care 2001, 24:1722-1727.
-
(2001)
Diabetes Care
, vol.24
, pp. 1722-1727
-
-
Tsui, E.1
Barnie, A.2
Ross, S.3
Parkes, R.4
Zinman, B.5
-
20
-
-
84867390400
-
Clinical outcomes of concomitant therapy of exenatide twice daily and basal insulin in patients with type 2 diabetes mellitus: a retrospective database analysis in the United States
-
Pawaskar M., Li Q., Hoogwerf B.J., Reynolds M.W., Lee L.J., Fonseca V. Clinical outcomes of concomitant therapy of exenatide twice daily and basal insulin in patients with type 2 diabetes mellitus: a retrospective database analysis in the United States. Endocr Pract 2012, 18:700-711.
-
(2012)
Endocr Pract
, vol.18
, pp. 700-711
-
-
Pawaskar, M.1
Li, Q.2
Hoogwerf, B.J.3
Reynolds, M.W.4
Lee, L.J.5
Fonseca, V.6
-
21
-
-
84927177790
-
Study of the relationship between socioeconomic status and controlling diabetes among patients admitted to specialized clinic of Dr Gharazi hospital in Isfahan-2011
-
Keyvanara M., Hosseini S.M., Emami P. Study of the relationship between socioeconomic status and controlling diabetes among patients admitted to specialized clinic of Dr Gharazi hospital in Isfahan-2011. J Educ Health Promot 2012, 1:28.
-
(2012)
J Educ Health Promot
, vol.1
, pp. 28
-
-
Keyvanara, M.1
Hosseini, S.M.2
Emami, P.3
-
22
-
-
79952133239
-
Country of birth, socioeconomic factors, and risk factor control in patients with type 2 diabetes: a Swedish study from 25 primary health-care centres
-
Sundquist K., Chaikiat A., León V.R., Johansson S.-E., Sundquist J. Country of birth, socioeconomic factors, and risk factor control in patients with type 2 diabetes: a Swedish study from 25 primary health-care centres. Diabetes Metab Res Rev 2011, 27(3):244-254.
-
(2011)
Diabetes Metab Res Rev
, vol.27
, Issue.3
, pp. 244-254
-
-
Sundquist, K.1
Chaikiat, A.2
León, V.R.3
Johansson, S.-E.4
Sundquist, J.5
-
23
-
-
84871710499
-
Exenatide twice daily: analysis of effectiveness and safety data stratified by age, sex, race, duration of diabetes, and body mass index
-
Pencek R., Blickensderfer A., Li Y., Brunell S.C., Anderson P.W. Exenatide twice daily: analysis of effectiveness and safety data stratified by age, sex, race, duration of diabetes, and body mass index. Postgrad Med 2012, 124:21-32.
-
(2012)
Postgrad Med
, vol.124
, pp. 21-32
-
-
Pencek, R.1
Blickensderfer, A.2
Li, Y.3
Brunell, S.C.4
Anderson, P.W.5
|